Ottawa – The Patented Medicine Prices Review Board (PMPRB) will launch the first phase of consultations on its new Guidelines by inviting stakeholders to participate in a Policy Roundtable on December 5 (English session) and December 6 (French session). The intent of this phase is to foster a productive conversation, where all parties can voice their opinions and concerns. At …